[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Michal Nowicki\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":32},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":18,"phases":4,"briefSummary":19,"conditions":20,"keywords":22,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":29,"locationsCount":4},"100236426","oms721-compassionate-use-in-patients-with-thrombotic-microangiopathy-100236426",false,"NCT02355782","OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy","Provision of OMS721 to Patients With Thrombotic Microangiopathy Under Compassionate Use","Inclusion Criteria:\n\n* Have a diagnosis of thrombotic microangiopathy related to aHUS, TTP or stem cell transplant.\n* Have completed treatment in clinical trial OMS721-TMA-001.\n* Investigator determined that continued treatment with OMS721 could be beneficial.\n* Aged 18 years or older.\n\nExclusion Criteria:\n\n* Hypersensitivity to OMS721 or any excipients.\n* Have a serious medical condition that increases the risk of OMS721 treatment to the patient.","ALL","18 Years","EXPANDED_ACCESS","The purpose of this compassionate use study, for two patients with thrombotic microangiopathy, is to provide expanded access to patients who have participated in the clinical trial OMS721-TMA-001 and in whom improvement in their disease markers was observed while on treatment or to patients who could otherwise benefit from the treatment. This is a treatment protocol; not a research protocol.Therefore, only patients in study OMS721-TMA-001 deemed eligible by the investigator may participate.",[21],"Thrombotic Microangiopathy",[23],"TMA, aHUS, TTP, stem cell transplant-associated TMA","AVAILABLE","2015-04-14",{"date":27,"type":28},"2015-04-15","ESTIMATED",{"name":30,"class":31},"Michal Nowicki","OTHER",""]